Related Experiment Video
Updated: Apr 30, 2026

Characterization of a Novel Human Organotypic Retinal Culture Technique
Published on: June 9, 2021
Funding community eye care in Aotearoa: a preliminary cost estimate based on the Australian approach
Lucy Goodman1, Pushkar Silwal1, Niamh Taylor1
1The University of Auckland, School of Optometry and Vision Science, Auckland, New Zealand.
Introduction:
In Australia, Medicare-funded optometric eye examinations are available to eligible residents, and state-funded subsidies support specific population groups to access spectacles. Meanwhile, public funding for optometry services in Aotearoa New Zealand (NZ) is limited, and many people cannot access the services they need.
Aim:
This study aimed to estimate the cost of funding eye examinations and spectacle subsidies in NZ based on the Australian model.
Methods:
We identified publicly available data describing uptake of Medicare-funded optometry services (2022-2024) and the NSW Spectacles Program (2022-2023). We assumed that uptake would be similar across age groups, male/female gender, and ethnicity groups (First Nations Australians vs Māori or Pacific Peoples in NZ, and non-Indigenous Australians vs other New Zealanders) between the two countries, and applied Australia's uptake rates to NZ's 2024 population. The cost of itemised eye examinations was defined using the current Medicare rebates (eg A$66.15/~NZ$73.35 for comprehensive examinations) and Optometry Australia's recommended consultation fees (A$153.54/~NZ$170.24), and the median value of available state-level spectacle subsidy (A$200/~NZ$221.76).
Results:
Extrapolating Australian uptake rates to our population in NZ would see ~2.4 million examinations delivered per annum at a cost of NZ$143m (using the Medicare rebate) and NZ$349m (using Optometry Australia's rate), as well as ~60,500 spectacles dispensed at a cost of NZ$13m. Targeting eye examinations and spectacles only to Community Services Card holders would cost NZ$50m to NZ$102m annually.
Discussion:
Australia's eye care models may guide future policies in NZ with discussion needed on the most appropriate rebates to avoid exacerbating inequities.
More Related Videos
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Accessory Structures of the Eye
Microbiome of the Eye
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...

